NCT02408380View on ClinicalTrials.gov

Analysis of a Biomarker Signature in Patients With Multiple Sclerosis (MS) Treated With Gilenya (FTY720)

UnknownOBSERVATIONAL
Enrollment

216

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

September 30, 2015

Study Completion Date

December 31, 2015

Conditions
Multiple Sclerosis
Trial Locations (1)

H3A 2B4

RECRUITING

McGill University, Montreal

Sponsors

Collaborators (1)

Novartis Pharmaceuticals
All Listed Sponsors
collaborator

Novartis Pharmaceuticals

INDUSTRY

lead

McGill University

OTHER